Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

January 28, 2019

Canas v. Tyme Technologies, Inc. et al

Track this case

Case Number:

1:19-cv-00843

Court:

New York Southern

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Ronnie Abrams

Firms

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. January 29, 2019

    Investor Sues Drugmaker Over Lack Of Control Group In Trials

    An investor in drugmaker Tyme Technologies Inc. filed suit against the biotechnology company in New York federal court on Monday, claiming its failure to include a control group in clinical trials for a new pancreatic cancer treatment led to a 35 percent drop in its share price earlier this month.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login